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Depressive and anxiety disorders are highly prevalent in the
general population,1 and have an enormous impact on physical,
social and occupational functioning.2–6 These severe impairments
may be long-lasting because depressive and anxiety disorders
frequently have a persistent course.7–11 Identification of risk
factors that predict unfavourable outcomes may provide
important insights into processes involved in the natural course
of these disorders and is essential for optimising treatment
strategies. Alcohol use disorders (abuse and dependence) are highly
prevalent in people with depression and/or anxiety,12–15 and have
been suggested to be important predictors of a poor outcome.
However, few prospective studies have examined the effects of
alcohol use disorders on the natural course of depressive and
anxiety disorders, and these have reported conflicting results.
For example, people with comorbid alcoholism have a decreased
risk of remission of major depressive disorder,16 and in addition
remission of generalised anxiety disorder is less likely in people
with comorbid substance use disorders.17 However, other studies
failed to find alcohol use disorders to be significant predictors
of the persistence of disorder among people who had depression
or anxiety.11,18 These inconsistent findings may be partly
explained by these studies’ lack of power owing to small sample
sizes (n=588, n= 473, n= 400 and n= 92 respectively).11,16–18
Therefore, we prospectively examined the 2-year course of
depressive and/or anxiety disorders in a large sample of
participants with current depression and/or anxiety (n= 1369).
Another possible explanation for the inconsistent results is
the heterogeneity of alcohol use disorders. Previous studies have
shown that alcohol dependence has strong cross-sectional
associations with depressive and/or anxiety disorders, whereas
alcohol abuse has not.14,15 It may, therefore, be important to
examine the unique associations of each condition on the natural
course of depressive and anxiety disorders. In addition, it may be
necessary to take into account the severity of alcohol abuse
and dependence, since these conditions have a dimensional
aspect.19–21 Consequently, our study not only examined whether
the presence of an alcohol use disorder predicts the course of
depressive and/or anxiety disorders, but also explored whether this
association is conditional on the type of alcohol use disorder
(abuse or dependence) or the severity of each condition. In
addition, we examined whether found associations might be due
to or independent of baseline severity of depressive and/or anxiety
disorders, and of psychosocial and treatment factors.
Method
Study sample
Data were derived from the Netherlands Study of Depression and
Anxiety (NESDA), an ongoing cohort study aimed at examining
the long-term course and consequences of depressive and
anxiety disorders in the adult population (aged 18–65 years). A
total of 2981 persons were included at the baseline assessment
in 2004–7, consisting of a healthy control group, people with a
history of depressive or anxiety disorder and people with current
depressive and/or anxiety disorder. Participants were recruited
from community (19%), primary care (54%) and out-patient
mental healthcare services (27%). Community-based participants
had previously been identified in a population-based study.
Primary care participants were identified through a three-stage
screening procedure, involving the 10-item Kessler questionnaire
and the Short Form Composite International Diagnostic Interview
(CIDI),22,23 conducted by telephone among a random sample of
patients of 65 general practitioners. Mental healthcare participants
were recruited consecutively when newly enrolled at one of the 17
participating mental health organisation locations. People with
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Background
Inconsistent findings have been reported on the role of
comorbid alcohol use disorders as risk factors for a
persistent course of depressive and anxiety disorders.
Aims
To determine whether the course of depressive and/or
anxiety disorders is conditional on the type (abuse or
dependence) or severity of comorbid alcohol use disorders.
Method
In a large sample of participants with current depression
and/or anxiety (n=1369) we examined whether the presence
and severity of DSM-IV alcohol abuse or alcohol dependence
predicted the 2-year course of depressive and/or anxiety
disorders.
Results
The persistence of depressive and/or anxiety disorders at the
2-year follow-up was significantly higher in those with
remitted or current alcohol dependence (persistence 62%
and 67% respectively), but not in those with remitted or
current alcohol abuse (persistence 51% and 46%
respectively), compared with no lifetime alcohol use disorder
(persistence 53%). Severe (meeting six or seven diagnostic
criteria) but not moderate (meeting three to five criteria)
current dependence was a significant predictor as 95% of
those in the former group still had a depressive and/or
anxiety disorder at follow-up. This association remained
significant after adjustment for severity of depression and
anxiety, psychosocial factors and treatment factors.
Conclusions
Alcohol dependence, especially severe current dependence,
is a risk factor for an unfavourable course of depressive and/
or anxiety disorders, whereas alcohol abuse is not.
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insufficient command of the Dutch language or a primary clinical
diagnosis of bipolar disorder, obsessive–compulsive disorder,
severe substance use disorder, psychotic disorder or organic
psychiatric disorder, as reported by them or their mental health
practitioner, were excluded. The research protocol was approved
by the ethical committee of participating universities and all
participants provided written informed consent. A detailed
description of the NESDA study design, sampling procedures
and response rates can be found elsewhere.24,25 In our earlier
research we examined non-response at the baseline interview: in
participants recruited from primary care (the majority), mainly
sociodemographic factors – namely younger age and male gender
– but not mental health status predicted higher non-response.25
Similar observations were found in the community and mental
healthcare settings.24 This suggests that our overall sample is
generalisable to the sample from which it was recruited, although
younger men may be slightly underrepresented.
The baseline assessment included a face-to-face assessment of
demographic and personal characteristics as well as a standardised
diagnostic psychiatric interview among all 2981 NESDA partici-
pants. After 2 years, another face-to-face assessment including
the same standardised diagnostic psychiatric interview was
conducted, with a response of 87.1% (n=2596; see Lamers et al
also for sociodemographic and psychiatric determinants of non-
response).26 For this study we selected all participants with major
depressive disorder, dysthymia, social phobia, panic disorder and/
or generalised anxiety disorder that was present within the 6
months prior to the baseline assessment (n=1641). Of these,
1369 persons (83.4%) had complete data at the 2-year follow-up
assessment and formed the sample for the analyses presented here.
The non-response group was significantly younger (P=0.03), less
educated (P50.001) and more often had a current depressive
disorder (P= 0.003) at baseline compared with the responder
group, whereas gender (P=0.16), alcohol abuse/dependence status
(P= 0.74) and current anxiety disorder (P= 0.07) were not
associated with failure to respond.
Measures
Depressive and anxiety disorders
Diagnoses of psychiatric disorders according to DSM-IV criteria27
were established with the CIDI version 2.1, administered by
specially trained research staff.23 The CIDI has shown high
interrater and test–retest reliability and high validity for depressive
and anxiety disorders.23 To examine the course of depressive and/
or anxiety disorders, we considered the persistence of the disorder
as well as the course of symptoms.
Persistence. Participants were considered to have persistent
disorder if they met DSM-IV criteria for a depressive and/or
anxiety disorder in the 6 months prior to the 2-year follow-up
assessment.
Symptoms. To assess the robustness of findings regarding the
persistence of these disorders, the course of symptoms during
the 2-year follow-up was used as a secondary outcome. Depressive
symptoms were defined as the total score on the 30-item self-
report Inventory of Depressive Symptomatology (IDS);28 anxiety
symptoms were defined as the total score on the 21-item self-
report Beck Anxiety Inventory (BAI).29 Both questionnaires
related to symptoms in the week prior to assessment. In addition
to the baseline and 2-year follow-up interviews, the IDS and
BAI were also administered at an intermittent 1-year follow-up
assessment.
Alcohol use disorder
Diagnoses of alcohol use disorder (DSM-IV criteria) were
established at baseline with the CIDI, which is a reliable and valid
instrument for assessing alcohol dependence, but with more
variable results for alcohol abuse.30 A DSM-IV diagnosis of
alcohol abuse requires one or more of the four abuse criteria to
be met, whereas a diagnosis of alcohol dependence requires three
or more of the seven dependence criteria. The CIDI hierarchy
criteria for diagnosing DSM-IV alcohol use disorders exclude the
possibility of a diagnosis of alcohol abuse when a lifetime
diagnosis of alcohol dependence is present. A distinction was
made between alcohol use disorders that were present in the 6
months prior to the baseline assessment (current disorder) v.
before this period (remitted disorder). Various alcohol use
disorder measures were assessed to examine the exact effects of
this disorder on the course of depressive and/or anxiety disorders.
Alcohol use disorder status. Alcohol use disorder status – no
lifetime alcohol use disorder (reference category), remitted
disorder or current disorder – was used to examine whether these
categories predicted the course of depressive and/or anxiety
disorders.
Alcohol abuse/dependence status. To determine whether DSM-IV
alcohol abuse and dependence have differential effects on the
course of depressive and/or anxiety disorders, we distinguished
between participants with no lifetime alcohol use disorder
(reference category), remitted alcohol abuse, current abuse,
remitted dependence and current dependence.
Alcohol abuse/dependence severity. The severity of current
alcohol abuse and dependence diagnoses was defined by the
number of criteria met, i.e. one to four criteria for alcohol abuse
and three to seven criteria for dependence. Previous studies have
shown that alcohol abuse and dependence have a dimensional
aspect,19,20 and that the count of alcohol dependence criteria
constitutes a linear dimension of alcohol dependence severity.21
Covariates
Basic covariates comprised gender, age (in years) and smoking
status (never smoked, former smoker, current smoker) at baseline.
To examine the role of baseline severity of depressive and/or
anxiety disorders, psychosocial factors and treatment factors in
the association between alcohol use disorders and the course of
depressive and/or anxiety disorders, analyses were additionally
adjusted for the following covariates.
Severity of depression and anxiety
Severity of depression and anxiety was defined as the severity of
symptoms at baseline assessed with the IDS and BAI respectively.
Psychosocial factors
Psychosocial factors included education (in years), employment
status (no/yes) and partner status (no/yes) at the baseline
assessment.
Treatment factors
Treatment factors consisted of frequent use of antidepressants,
frequent use of benzodiazepines and psychological treatment at
the baseline interview and/or during follow-up. Frequent use of
psychoactive medication was assessed by drug container
inspection of medication used in the month before the baseline
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or 2-year follow-up assessment, classified according to the World
Health Organization Anatomical Therapeutic Chemical (ATC)
classification,31 and was considered to be present when the
medication was taken daily or on at least half of the days. We
distinguished between use of antidepressants – selective serotonin
reuptake inhibitors (ATC code N06AB), tricyclic antidepressants
(N06AA) and other antidepressants (N06AF/N06AX) – and use
of benzodiazepines (ATC codes N03AE, N05BA, N05CD and
N05CF). The receipt of psychological treatment (formal
psychotherapy, counselling or skills training) in the 6 months
prior to the baseline or 2-year follow-up assessment was based
on self-reported information.
Statistical analysis
Analyses were conducted using SPSS version 15.0 for Windows.
First, baseline characteristics of the sample were summarised using
descriptive statistics. To examine whether alcohol use disorder sta-
tus (no lifetime disorder, remitted disorder or current disorder)
predicted the presence of depressive and/or anxiety disorders at
the 2-year follow-up, logistic regression analyses were used. We
then focused on the type of alcohol use disorder by examining
the associations across alcohol abuse/dependence status: no
lifetime alcohol use disorder (reference category), remitted
alcohol abuse, current abuse, remitted dependence and current
dependence.
We further explored the relationships of current alcohol abuse
and dependence with the presence of depressive and/or anxiety
disorders at the 2-year follow-up by focusing on the severity of
the current alcohol use disorder. A graph was plotted based on
logistic regression analyses with variables representing all separate
levels of abuse severity (one to four criteria) or dependence
severity (three to seven criteria) as predictors. We used the Wald
statistic to test whether a model based on alcohol abuse or
dependence severity better predicted the presence of depressive
and/or anxiety disorders at 2-year follow-up than the model based
on DSM-IV alcohol use disorder diagnoses, an analytic method
used previously by others.21 All analyses were adjusted for gender,
age and smoking status.
To test the robustness of our findings, we additionally examined
the course of depressive symptoms as well as anxiety symptoms
using linear mixed models (LMM) analyses. Alcohol abuse/
dependence status, time of assessment (baseline, 1-year follow-up,
2-year follow-up) and covariates were entered as fixed factors,
participants were treated as a random effect and a random
intercept was estimated. To determine whether groups based on
alcohol abuse/dependence status differed in their overall levels of
depressive and anxiety symptoms, we considered the direct effects
of alcohol use disorder groups. In addition, we added a group6
time interaction term to examine whether the trajectories of
depressive and anxiety symptoms differed across the groups.
Similarly, we used LMM analyses to examine whether the
alternative model based on abuse/dependence severity predicted
the course of depressive and anxiety disorders. To examine the role
of other factors in the association between alcohol use disorders
and the persistence of depressive and/or anxiety disorders,
analyses were additionally adjusted for covariates involving
baseline severity of depression and anxiety (IDS and BAI total
scores), psychosocial factors (education, employment status and
partner status) and treatment factors (use of antidepressants,
use of benzodiazepines and psychological treatment).
Results
Our sample (n=1369) had a mean age of 41.3 years (s.d. = 12.3)
and two-thirds (66.3%) were women; 935 persons (68.3%) had
never had an alcohol use disorder, 307 (22.4%) had a remitted
alcohol use disorder and 127 (9.3%) had a current alcohol use
disorder (Table 1).
Alcohol use disorder status
We examined whether alcohol use disorder status predicted the
presence of depressive and/or anxiety disorders after 2-year
follow-up, adjusted for basic covariates. Neither remitted nor
current alcohol use disorder was a significant predictor of an
unfavourable course of depressive disorder and/or anxiety
disorder compared with those with no lifetime alcohol use
disorder (Table 2).
Type of alcohol use disorder
We tested whether alcohol abuse and dependence had differential
effects on the course of depressive and/or anxiety disorders,
adjusted for basic covariates (Table 2). Participants with
depression and/or anxiety with remitted alcohol dependence
(persistence: 62.4%; odds ratio (OR)= 1.42, 95% CI 1.02–1.97,
P= 0.04) and those with current alcohol dependence (persistence:
66.7%; OR= 1.69, 95% CI 1.04–2.75, P= 0.04) had a significantly
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Table 1 Sample characteristics at baseline (n = 1369)
Basic covariates
Gender, female, n (%) 907 (66.3)
Age, years: mean (s.d.) 41.3 (12.3)
Smoking, n (%)
Non-smoker 363 (26.5)
Former smoker 430 (31.4)
Current smoker 576 (42.1)
Severity of depression and anxiety
Depressive symptoms (IDS total score): mean (s.d.) 28.9 (12.2)
Anxiety symptoms (BAI total score): mean (s.d.) 16.7 (10.4)
Psychosocial factors
Education, years: mean (s.d.) 11.9 (3.3)
Employment (yes), n (%) 758 (55.4)
Partner (yes), n (%) 890 (65.0)
Treatment, n (%)
Use of antidepressants (yes) 632 (46.2)
Use of benzodiazepines (yes) 239 (17.5)
Psychological treatment (yes) 915 (66.8)
AUD measures, n (%)
AUD status
No lifetime AUD 935 (68.3)
Remitted AUD 307 (22.4)
Current AUD 127 (9.3)
AA/AD status
No lifetime AUD 935 (68.3)
Remitted AA 113 (8.3)
Current AA 46 (3.4)
Remitted AD 194 (14.2)
Current AD 81 (5.9)
Number of current AA criteria, n (%)
One 44 (3.2)
Two 2 (0.1)
Three 0 (0.0)
Four 0 (0.0)
Number of current AD criteria, n (%)
Three 26 (1.9)
Four 22 (1.6)
Five 13 (0.9)
Six 12 (0.9)
Seven 8 (0.6)
AA, alcohol abuse; AD, alcohol dependence; AUD, alcohol use disorder; BAI, Beck
Anxiety Inventory; IDS, Inventory of Depressive Symptomatology.
Alcohol use disorders and depression/anxiety
increased risk of having a persistent depressive and/or anxiety dis-
order at the 2-year follow-up compared with participants with no
lifetime alcohol use disorder (persistence: 53.2%). In contrast,
neither remitted nor current alcohol abuse significantly predicted
the presence of depressive and/or anxiety disorders after 2 years.
We tested the robustness of these findings with LMM analyses
adjusted for basic covariates (Fig. 1). Over the entire follow-up
period, participants with remitted and current alcohol dependence
had significantly higher overall levels of depressive symptoms and
a trend was found for anxiety symptoms (see Table 3 for
probability values), with similar course trajectories over time
(P50.10 for all interactions remitted dependence6time or
current dependence6time), compared with participants with no
lifetime alcohol use disorder. Neither the overall levels nor the
course trajectories of depressive and anxiety symptoms were
significantly worse for people with remitted or current alcohol
abuse.
Severity of alcohol abuse and dependence
A third aim of our study was to examine whether the associations
of current alcohol abuse and dependence with the course of
depressive and/or anxiety disorders were conditional on the
severity of each condition. Analyses of alcohol abuse severity
appeared to be impossible, since of the 46 participants in the
current alcohol abuse group, 44 met only one DSM-IV abuse
criterion (see Table 1), so further analyses were restricted to the
severity of current alcohol dependence. A graph of the association
between the number of current alcohol dependence criteria and
the presence of depressive and/or anxiety disorders at the 2-year
follow-up (Fig. 2) indicated that this association was conditional
on the severity of dependence. Only people meeting six or seven
alcohol dependence criteria, and not those meeting three, four
or five criteria, were at an increased risk. To test this directly, we
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Table 2 Alcohol use disorder measures predicting the persistence of depressive and/or anxiety disorder at 2-year follow-up
Persistence of depressive/anxiety disorder
Baseline AUD measure Rate, % ORa (95% CI) P
AUD status
No lifetime AUD 53.2 Reference
Remitted AUD 58.3 1.21 (0.92–1.60) 0.17
Current AUD 59.1 1.27 (0.86–1.86) 0.23
AA/AD status
No lifetime AUD 53.2 Reference
Remitted AA 51.3 0.94 (0.63–1.40) 0.75
Current AA 45.7 0.79 (0.43–1.45) 0.45
Remitted AD 62.4 1.42 (1.02–1.97) 0.04
Current AD 66.7 1.69 (1.04–2.75) 0.04
AD severity
No lifetime AUD 53.2 Reference
Moderate current AD (3–5 criteria) 57.4 1.11 (0.65–1.89) 0.69
Severe current AD (6 or 7 criteria) 95.0 17.15 (2.27–129.51) 0.006
AA, alcohol abuse; AD, alcohol dependence; AUD, alcohol use disorder; OR, odds ratio.
a. Based on logistic regression analyses, adjusted for basic covariates (gender, age and smoking status).
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Fig. 1 Alcohol abuse and dependence status predicting the
course of (a) depressive symptoms and (b) anxiety symptoms.
Based on linear mixed model analyses, adjusted for basic covariates (gender, age
and smoking status). Probability values are given in Table 3. AA, alcohol abuse;
AD, alcohol dependence; AUD, alcohol use disorder; BAI, Beck Anxiety Inventory;
IDS, Inventory of Depressive Symptomatology.
Table 3 Probability values for prediction of course of
symptoms by alcohol abuse and dependence status (see Fig. 1)
Depressive symptoms Anxiety symptoms
Direct
effect
P
Time
interaction
P
Direct
effect
P
Time
interaction
P
Remitted AA 0.80 0.91 0.70 0.26
Current AA 0.03 0.25 0.02 0.24
Remitted AD 0.02 0.91 0.07 0.67
Current AD 0.04 0.54 0.18 0.10
AA, alcohol abuse; AD, alcohol dependence.
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used a model distinguishing no lifetime alcohol use disorder,
‘moderate’ current alcohol dependence (meeting three to five
criteria) and ‘severe’ current alcohol dependence (six or seven
criteria). This two-level model explained the relationship with
the persistence of depressive and/or anxiety disorders better than
the original DSM-IV model which made no distinction based on
severity of alcohol dependence (w2 = 7.10, d.f. = 1, P= 0.008).
Additional analyses, taking moderate alcohol dependence as the
reference group, showed a significant difference between people
with severe alcohol dependence and those with moderate
dependence (unadjusted OR=14.11, 95% CI 1.77–112.29,
P= 0.01), indicating that severe alcohol dependence had a
significantly stronger effect on the persistence of depressive and/
or anxiety disorders.
Table 2 shows that 95.0% of participants with severe alcohol
dependence still had a depressive and/or anxiety disorder after
the 2-year follow-up, which was significantly higher than in those
with no lifetime alcohol use disorder (basic adjustment:
OR= 17.15, 95% CI 2.27–129.51, P=0.006). No significant
association was found for participants with moderate alcohol
dependence (basic adjustment: OR= 1.11, 95% CI 0.65–1.89,
P= 0.69). To verify our findings regarding the persistence of
depressive and/or anxiety disorders at 2 years follow-up, we
additionally tested whether moderate alcohol dependence and
severe alcohol dependence predicted the course of depressive
and anxiety symptoms using LMM analyses (Fig. 3). These results
showed that the overall levels of depressive and anxiety symptoms
were higher for those with severe current alcohol dependence and
that, in addition, the course trajectories for depressive and anxiety
symptoms were poorer compared with those with no lifetime
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Fig. 2 Number of current alcohol dependence criteria
predicting the persistence of depressive and/or anxiety disorder
at 2-year follow-up. AD, alcohol dependence; AUD, alcohol use
disorder.
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Fig. 3 Moderate and severe current alcohol dependence
predicting the course of (a) depressive symptoms and (b) anxiety
symptoms.
Based on linear mixed model analyses, adjusted for basic covariates (gender, age,
and smoking status). Probability values are given in Table 4. AD, alcohol dependence;
AUD, alcohol use disorder; BAI, Beck Anxiety Inventory; IDS, Inventory of Depressive
Symptomatology.
Table 4 Probability values for persistence of depressive and/or anxiety disorder predicted by severity of current alcohol
dependence (see Fig. 3)
Depressive symptoms Anxiety symptoms
Direct effect
P
Time interaction
P
Direct effect
P
Time interaction
P
Moderate current AD (3–5 criteria) 0.33 0.89 0.63 0.61
Severe current AD (6 or 7 criteria) 0.01 0.02 0.06 0.02
AD, alcohol dependence.
Alcohol use disorders and depression/anxiety
alcohol use disorder (P values are summarised in Table 4). No
significant difference in the course of depressive or anxiety
symptoms was found for moderate alcohol dependence.
Role of other factors
To explore the role of other factors in the association between
severity of alcohol dependence and the persistence of depressive
and/or anxiety disorders, the analyses were additionally adjusted
for baseline severity of depression and anxiety (Table 5, second
column), psychosocial factors (third column) and treatment
factors (fourth column). In the analyses adjusted for basic
covariates, severe current alcohol dependence was a significant
predictor of the persistence of depressive and/or anxiety disorders
(OR= 17.15, 95% CI 2.27–129.51, P= 0.006). Although the
association was slightly decreased after additional adjustment for
severity of depressive and anxiety symptoms (OR= 15.88, 95%
CI 2.09–120.87, P=0.008), psychosocial factors (OR=15.22, 95%
CI 1.99–116.16, P=0.009) and treatment factors (OR= 13.50,
95% CI 1.77–102.96, P=0.01), the association remained significant
(Table 5).
Heterogeneity of depressive and anxiety disorders
At the baseline assessment, 60.4% of all the participants who had
current depression also had a current anxiety disorder. Similarly,
57.4% of participants with current anxiety also had a current
depressive disorder. Given the high comorbidity of depressive
and anxiety disorders, previous analyses were based on a mixed
group of people with a depressive and/or anxiety disorder. To
assess the robustness of our findings, a set of sensitivity analyses
was conducted. First, we tested whether alcohol abuse/dependence
status predicted the presence of a depressive and/or anxiety
disorder at the 2-year follow-up in a subsample of participants
with depressive disorders (n= 946) v. those with anxiety disorders
(n=994). We found consistent associations for remitted alcohol
abuse (unadjusted OR= 0.69, P= 0.12 v. unadjusted OR=1.06,
P= 0.80), current alcohol abuse (unadjusted OR=0.58, P= 0.14
v. unadjusted OR= 0.74, P= 0.43), remitted alcohol dependence
(unadjusted OR= 1.26, P= 0.25 v. unadjusted OR=1.67,
P=0.04) and current alcohol dependence (unadjusted OR=1.47,
P= 0.16 v. unadjusted OR= 1.75, P= 0.05). In addition, severe
current alcohol dependence was a significant predictor in parti-
cipants with depressive disorders (unadjusted OR=11.26,
P= 0.02) and anxiety disorders (unadjusted OR=10.29,
P= 0.03), whereas moderate current alcohol dependence was not
significant in either subsample (unadjusted OR= 0.99, P= 0.96
v. unadjusted OR= 1.28, P=0.43).
Discussion
To our knowledge this is the first study showing that the
association between alcohol use disorders and the course of
depressive and/or anxiety disorders is conditional on the type
(abuse or dependence) and severity of the alcohol use disorder.
Our results show that current dependence as well as a history of
alcohol dependence, but not abuse, predicts an unfavourable
course of depressive and/or anxiety disorders. People with severe
current alcohol dependence (six or seven alcohol dependence
criteria) have an especially poor course since 95% have a persistent
depressive and/or anxiety disorder, in contrast to 53% of those
with no lifetime alcohol use disorder. In addition, depressive
and anxiety symptoms remain significantly higher in people with
severe current alcohol dependence, whereas they generally
481
Table 5 Alcohol use disorder measures predicting the persistence of depressive and/or anxiety disorders at 2-year follow-up
Persistence of depressive/anxiety disorder after 2 years
Basic adjustmenta
Additionally adjusted for
symptom severityb
Additionally adjusted for
psychosocial factorsc
Additionally adjusted for
treatment factorsd
OR (95% CI) P OR (95% CI) P OR (95% CI) P OR (95% CI) P
AD severity
No lifetime AUD Reference Reference Reference Reference
Moderate current AD 1.11 (0.65–1.89) 0.71 1.03 (0.59–1.80) 0.92 1.00 (0.57–1.75) 1.00 0.97 (0.55–1.72) 0.93
Severe current AD 17.15
(2.27–129.51)
0.006 15.88
(2.09–120.87)
0.008 15.22
(1.99–116.16)
0.009 13.50
(1.77–102.96)
0.01
Basic covariates
Gender (female) 1.11 (0.83–1.48) 0.49 1.13 (0.83–1.53) 0.43 1.12 (0.83–1.52) 0.46 1.12 (0.82–1.52) 0.48
Age 1.01 (1.00–1.02) 0.01 1.01 (1.00–1.02) 0.08 1.01 (1.00–1.02) 0.08 1.01 (1.00–1.03) 0.02
Smoking status
Non-smoker Reference Reference Reference Reference
Former smoker 1.36 (0.98–1.88) 0.06 1.21 (0.86–1.70) 0.27 1.19 (0.84–1.67) 0.33 1.17 (0.83–1.65) 0.37
Current smoker 1.65 (1.21–2.25) 0.002 1.43 (1.03–1.98) 0.03 1.42 (1.02–1.98) 0.04 1.43 (1.02–1.99) 0.04
Severity of depression and anxiety
Depressive symptoms (IDS score) 1.05 (1.04–1.07) 50.001 1.05 (1.03–1.07) 50.001 1.05 (1.03–1.06) 50.001
Anxiety symptoms (BAI score) 1.01 (0.99–1.02) 0.37 1.01 (0.99–1.03) 0.32 1.01 (0.99–1.02) 0.38
Psychosocial factors
Education in years 1.01 (0.97–1.06) 0.53 1.00 (0.96–1.05) 0.84
Employment (yes) 0.90 (0.69–1.18) 0.46 0.91 (0.69–1.20) 0.51
Partner (yes) 0.91 (0.69–1.21) 0.53 0.91 (0.68–1.21) 0.51
Treatment factors
Use of antidepressants (yes) 1.00 (0.76–1.32) 1.00
Use of benzodiazepines (yes) 0.91 (0.64–1.30) 0.62
Psychological treatment (yes) 1.63 (1.20–2.20) 0.002
AD, alcohol dependence; AUD, alcohol use disorder; BAI, Beck Anxiety Inventory; IDS, Inventory of Depressive Symptomatology; OR, odds ratio.
a. Adjusted for basic covariates (gender, age, smoking status).
b. Adjusted for basic covariates and depressive/anxiety symptoms (baseline IDS and BAI scores).
c. Adjusted for basic covariates, depressive/anxiety symptoms and psychosocial factors (education, employment status, partner status).
d. Adjusted for basic covariates, depressive/anxiety symptoms, psychosocial factors and treatment factors (use of antidepressants, use of benzodiazepines and psychological treatment).
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improve in those with no lifetime alcohol use disorder. The
inconsistent findings of previous studies reporting that alcohol
use disorders predicted an unfavourable course of depressive or
anxiety disorders,16,17 or did not,11,18 may therefore be explained
by the differential effects of alcohol use disorders depending on
the type and severity.
Possible mechanisms
Our study further demonstrated that severe current alcohol
dependence predicted the persistence of depressive and/or anxiety
disorders, even after taking into account the effects of other risk
factors. Although baseline severity of depressive and anxiety
symptoms, psychosocial factors and treatment partly explained
the association, severe alcohol dependence remained a strong
predictor. Previous studies have proposed that interpersonal and
social problems, as characteristics of alcohol use disorders, cause
the persistence of depressive and/or anxiety disorders.32 This
may be supported by our finding that the risk of persistent
depressive and/or anxiety disorders was increased only in people
with severe alcohol dependence. Previous studies have found that
the alcohol dependence criterion involving interpersonal and
social problems (criterion 6: giving up or reducing occupational,
social and/or recreational activities to drink) is one of the most
severe criteria and is mainly present in those with severe alcohol
use disorders.33 This was supported by some additional analyses
showing that this specific criterion was present in 85% of
participants with severe alcohol dependence v. 15% of those with
moderate alcohol dependence. Similarly, DSM-IV alcohol abuse
criteria involving interpersonal and social problems (criterion 1:
failure to fulfil major role obligations; criterion 4: persistent social
or interpersonal problems) are more likely in people with severe
alcohol use disorders;34 the prevalence rates of alcohol abuse
criteria 1 and 4 in participants with severe alcohol dependence
in our sample were 60% and 100% respectively. Although factors
involving general psychosocial status (level of education,
employment status and partner status) did not explain the
association between severe current alcohol dependence and the
persistence of depressive and/or anxiety disorders, factors
involving the quality of interpersonal and social life (giving up
activities, failure to fulfil roles, and persistent social or inter-
personal problems), as characteristics of severe alcohol
dependence, may have a more important role. Further research
is needed to unravel the exact mechanisms through which (severe)
current alcohol dependence leads to an unfavourable course of
depressive and/or anxiety disorders.
Clinical implications
Our finding that (severe) current alcohol dependence leads to an
unfavourable course of depressive and/or anxiety disorders stresses
the importance of integrating addiction treatment in general
mental health services to optimise treatment for patients with
depression and/or anxiety with comorbid alcohol dependence.
This has the potential to be highly effective, since 95% of our
sample with severe current alcohol dependence had a persistent
depressive and/or anxiety disorder after 2 years. Integrated care
has also been advocated by others as a means of enhancing
communication between care providers, reducing stigma and
avoiding artificial separation of various psychiatric problems that
otherwise could result in substandard care.34,35 To identify
individuals with alcohol dependence, time-efficient screening
instruments such as the Alcohol Use Disorder Identification Test
(AUDIT) could be helpful.36 This test has been shown to be
accurate in detecting alcohol dependence in individuals with
depression and anxiety,37 and therefore may be effective in
identifying patients with depression and/or anxiety who need
additional addiction treatment.
Alcohol use disorder in DSM-5
We showed that alcohol abuse, unlike dependence, does not
predict the course of depressive and/or anxiety disorders. A
similar pattern of results was found in other studies reporting that
alcohol abuse was not more prevalent in people with anxiety and/
or depression, in contrast to dependence.14,15 Since others found
that the reliability and validity were excellent for a DSM-IV
diagnosis of alcohol dependence but not for a diagnosis of alcohol
abuse,29,36 this raises the question whether alcohol abuse as
diagnosed by DSM-IV criteria (i.e. hierarchically assessed based
on one or more criteria) should be considered a genuine
psychiatric disorder. This may be supported by our finding that
of the 46 persons with current alcohol abuse in our sample, all
but 2 met only one criterion. Although the reliability and validity
of a diagnosis of alcohol abuse were low, studies have shown that
the individual criteria of alcohol dependence as well as abuse are
reliable and valid, and represent a single latent dimension with
dependence and abuse criteria interspersed across an underlying
severity spectrum.37–39 Together, these findings have motivated
the DSM-5 work group to propose one diagnosis of an alcohol
use disorder that is based on alcohol abuse as well as dependence
criteria, with different levels of severity. The importance of using
severity indicators rather than categorical diagnoses is also
highlighted by our finding that only those with severe alcohol
dependence (meeting six or seven criteria) and not those with
moderate alcohol dependence (meeting three to five criteria) have
an unfavourable course of depressive and/or anxiety disorders.
Severity of disorder may therefore be more informative than pure
diagnosis, as has already been indicated by others.37–41
Strengths and limitations
Methodological strengths of our study include that we
prospectively examined whether DSM-IV alcohol abuse and
alcohol dependence predicted the course of disorders in a large
sample of people with a DSM-IV diagnosis of a depressive and/
or anxiety disorder. This sample consisting of 1369 persons was
much larger than the 92 to 588 persons who participated in
previous studies on this topic.11,16–18 In addition, our main
findings regarding the persistence of depressive and/or anxiety
disorders were all supported by additional analyses on the course
of depressive and anxiety symptoms. Despite the large sample size,
a limitation of our study is the small number of participants with
severe alcohol use disorders. In addition, people with a primary
diagnosis of a severe substance use disorder were not included
in this study. Therefore, reported associations between alcohol
use disorders and the course of depressive and/or anxiety
disorders are likely to be underestimates and may not be
generalised to severe alcohol use disorders. Studies in clinical
samples of patients with severe alcohol use disorders, with or
without comorbid substance use disorders, should provide
important additional information. Although consistent findings
were found for participants with a depressive disorder v. an
anxiety disorder, further research is needed to assess associations
between alcohol use disorders and specific depressive and anxiety
disorders.
Concluding remarks
The effects of comorbid alcohol use disorders on the course of
depressive and/or anxiety disorders are conditional on the type
as well as severity of the former disorders. Alcohol dependence,
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especially severe current dependence, predicts an unfavourable
course of depressive and/or anxiety disorders, whereas alcohol
abuse does not. Of the group with severe current alcohol
dependence, 95% had a persistent depressive and/or anxiety
disorder without symptomatic improvement. This stresses the
importance of integrating addiction treatment in general mental
health services as a means of optimising treatment outcomes for
patients with depression and/or anxiety.
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Cancer Winter (excerpts)
Marilyn Hacker
I woke up, and the surgeon said, ‘You’re cured.’
Strapped to the gurney, in the cotton gown
and pants I was wearing when they slid me down
onto the table, made news straps secure
while I stared at the hydra-headed O.R.
lamp, I took in the tall, confident, brown-
skinned man, and the ache I couldn’t quite call pain
from where my right breast wasn’t anymore
to my armpit. A not-yet-talking head,
I bit dry my lips. What else could he have said?
And then my love was there in a hospital coat;
then my old love, still young and very scared.
Then I, alone, graphed clock hands’ asymptote
to noon, when I would be wheeled back upstairs.
( . . . )
The hand that held the cup next was my daughter’s
– who would be holding shirts for me to wear,
sleeve out, for my bum arm. She’d wash my hair
(not falling yet), strew teenager’s disorder
in the kitchen, help me out of the bathwater.
A dozen times, she looked at the long scar
studded with staples, where I’d suckled her,
and didn’t turn. She took me / I brought her
to the surgeon’s office, where she’d hold
my hand, while his sure hand, with its neat tool, snipped
the steel, as on a revised manuscript
radically rewritten since my star
turn nursing her without a ‘nursing bra’
from small, firm breasts, a twenty-five-year-old’s.
Excerpted from WINTER NUMBERS: Poems by Marilyn Hacker. Copyright s 1994 by Marilyn Hacker. Used with permission
of the publisher, W. W. Norton & Company, Inc.
Chosen by Femi Oyebode.
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